Diagnostics News and Research

RSS

New Mexico implements software module to link telemedicine services to other systems

New Mexico Software, a developer of medical IT services and solutions that enable improved and faster communication within the healthcare community, announced today the implementation of a software module that gives the company virtually unlimited ability to link its XR-EXpress telemedicine services to other systems.

27 Jan 2011

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

HTX announced today an agreement to establish GE's first global Pathology Imaging Centre of Excellence in Toronto, Ontario. GE Healthcare and its digital pathology joint venture, Omnyx™, will invest $7.75M along with a $2.25M grant from the Health Technology Exchange (HTX). Planned collaborative research and development (R&D) partnerships will bring an additional $7.2M, for a total investment of $17.2M over the next 3 years.

27 Jan 2011

QIAGEN announces formation of subsidiary in India

QIAGEN today announced the formation of its India subsidiary, QIAGEN India Pvt. Ltd., and the beginning of direct sales in the country. Until now, QIAGEN products have been sold in India through distributor partnerships.

From QIAGEN Manchester Limited 27 Jan 2011

FDA Advisory Committee recommends expanded indication for Abbott's RX ACCULINK Carotid Stent System

Abbott today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted that, for symptomatic and asymptomatic carotid artery disease patients at standard surgical risk, there is reasonable assurance that the benefits of the RX ACCULINK® Carotid Stent System outweigh its risks (Yes: 7, No: 3, Abstain: 1).

27 Jan 2011

Avantra begins shipment of new Q400 Biomarker Workstation and Angio Qx BioChip Immunoassay

Avantra® Biosciences, a leading innovator in protein diagnostics, announced today their first shipments of the new Q400 Biomarker Workstation and the innovative Angio Qx™ BioChip Immunoassay.

27 Jan 2011

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Researchers have invented a technique that uses inexpensive paper to make "microfluidic" devices for rapid medical diagnostics and chemical analysis.

27 Jan 2011

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2010.

27 Jan 2011

Quest Diagnostics releases new data on oral fluid testing system

OraSure Technologies, the market leader in oral fluid diagnostics, announced today that Quest Diagnostics Incorporated released new data indicating that oral fluid revealed approximately five times more heroin use in the general U.S. workforce than previously believed.

From Quest Diagnostics 27 Jan 2011

Nexstim closes additional equity financing for approximately EUR 11.4 million

Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.

27 Jan 2011

Next generation sequencing on the European growth path: Report

Next Generation Sequencers have found their way into service providing labs and the global biomedical research community. 2010 has seen a serious uptake of Next Generation Sequencing technology, and today it is perceived as an indispensable tool.

26 Jan 2011

Quest Diagnostics fourth quarter revenues decrease 1.3% to $1.8 billion

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2010, income from continuing operations was $167 million, or $0.97 per diluted share, compared to $182 million, or $0.97 per diluted share, for the fourth quarter of 2009.

From Quest Diagnostics 25 Jan 2011

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.

25 Jan 2011

NanoString Technologies launches nCounter Mouse miRNA Expression Assay Kit

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the expansion of its microRNA (miRNA) product line with a multiplexed assay for profiling the mouse miRNA transcriptome.

From NanoString Technologies 25 Jan 2011

IRIS International places 40 iQ200 Elite Automated Urine Microscopy Analyzers in Mexico in 2010

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory,has begun to significantly penetrate the Mexican healthcare market with the initial placement in 2010 of 40 iQ®200 Elite™ Automated Urine Microscopy Analyzers within one of the largest social security healthcare systems in Mexico.

25 Jan 2011

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

25 Jan 2011

Study results of Pathwork Diagnostics's Tissue of Origin Test presented at ASCO 2011

Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced today that results from a decision impact study of its Tissue of Origin Test were presented this weekend at the ASCO 2011 Gastrointestinal Cancers Symposium in San Francisco.

25 Jan 2011

Sanofi-aventis acquires world-wide license for ADC products

Oxford BioTherapeutics today announces that sanofi-aventis has acquired an exclusive world-wide license to one of OBT's internal preclinical antibody programs.

25 Jan 2011

FedEx launches Deep Frozen Shipping Solution for temperature-sensitive healthcare products

FedEx Corp. today announced the launch of FedEx Deep Frozen Shipping Solution, which offers an innovative end-to-end service for the shipping of temperature-sensitive healthcare products around the world.

24 Jan 2011

Alqaem and Biosign to exhibit UFIT TEN-20 non-invasive glucometer at 36th Arab Health Exhibition

ALQAEM International, exclusive Biosign master distributor for the Middle East and North Africa Region (M.E.N.A.) today announced that they will be joining with Biosign Technologies Inc, the Canadian manufacturer of the revolutionary UFIT TEN-20 non-invasive glucometer, to exhibit at the 36th Annual Arab Health Exhibition & Congress held in Dubai, UAE from January 24th to 27th, 2011 at Stand S1G61.

24 Jan 2011

Novartis enters definitive merger agreement to acquire Genoptix

Genoptix, announced today that it has entered into a definitive merger agreement to be acquired by Novartis. Under the terms of the merger agreement, Novartis will commence an all cash tender offer for all outstanding shares of common stock of Genoptix at USD$25.00 per share.

24 Jan 2011

Diagnostics News and Research

New Mexico implements software module to link telemedicine services to other systems

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

QIAGEN announces formation of subsidiary in India

FDA Advisory Committee recommends expanded indication for Abbott's RX ACCULINK Carotid Stent System

Avantra begins shipment of new Q400 Biomarker Workstation and Angio Qx BioChip Immunoassay

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Quest Diagnostics releases new data on oral fluid testing system

Nexstim closes additional equity financing for approximately EUR 11.4 million

Next generation sequencing on the European growth path: Report

Quest Diagnostics fourth quarter revenues decrease 1.3% to $1.8 billion

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

NanoString Technologies launches nCounter Mouse miRNA Expression Assay Kit

IRIS International places 40 iQ200 Elite Automated Urine Microscopy Analyzers in Mexico in 2010

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Study results of Pathwork Diagnostics's Tissue of Origin Test presented at ASCO 2011

Sanofi-aventis acquires world-wide license for ADC products

FedEx launches Deep Frozen Shipping Solution for temperature-sensitive healthcare products

Alqaem and Biosign to exhibit UFIT TEN-20 non-invasive glucometer at 36th Arab Health Exhibition

Novartis enters definitive merger agreement to acquire Genoptix

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News